Advanced search
Publication Cover
Future Neurology Volume 1, 2006 - Issue 5
Submit an article Journal homepage
170
Views
0
CrossRef citations to date
0
Altmetric
Review

Inborn errors affecting vitamin B6 metabolism

Robert Surteesa UCL Institute of Child Health, Neurosciences Unit, 30 Guilford Street, London, WC1N 1EH, UK. [email protected]
,
Philippa Millsb UCL Institute of Child Health, Biochemistry, Endocrinology & Metabolism Unit, 30 Guilford Street, London, WC1N 1EH, UK. [email protected]
&
Peter Claytonc UCL Institute of Child Health, Biochemistry, Endocrinology & Metabolism Units, 30 Guilford Street, London, WC1N 1EH, UK. [email protected]
Pages 615-620 | Published online: 25 Sep 2006

Bibliography

  • McCormick DB: Two interconnected B vitamins: riboflavin and pyridoxine. Physiol.Rev.69(4), 1170–1198 (1989).
  • Said HM : Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins.Ann. Rev. Physiol.66, 419–446 (2004).
  • Spector R , GreenwaldLL: Transport and metabolism of vitamin B6 in rabbit brain and choroid plexus.J. Biol. Chem.253(7), 2373–2379 (1978).
  • Waymire KG , MahurenJD, JajeJM, GuilarteTR, CoburnSP, MacGregorGR: Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6.Nat. Genet.11(1), 45–51 (1995).
  • Nunes ML , MugnolF, BicaI, FioriRM: Pyridoxine-dependent seizures associated with hypophosphatasia in a newborn.J. Child Neurol.17(3), 222–224 (2002).
  • Spector R : Vitamin B6 transport in the central nervous system: in vitro studies.J. Neurochem.30(4), 889–897 (1978).
  • Kang JH , HongML, KimDWet al.: Genomic organization, tissue distribution and deletion mutation of human pyridoxine 5'-phosphate oxidase.Eur. J. Biochem.271(12), 2452–2461 (2004).
  • Kwon O , KwokF, ChurchichJE: Catalytic and regulatory properties of native and chymotrypsin-treated pyridoxine-5-phosphate oxidase.J. Biol. Chem.266(33), 22136–22140 (1991).
  • John RA : Pyridoxal phosphate-dependent enzymes.Biochim. Biophys. Acta1248(2), 81–96 (1995).
  • Coursin DB : Convulsive seizures in infants with a pyridoxine deficient diet.JAMA154, 406–408 (1954).
  • Mills PB , SurteesRA, Champion MPet al.: Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. Hum. Mol. Genet.14(8), 1077–1086 (2005).
  • Walker V , MillsGA, PetersSA, MertonWL: Fits, pyridoxine, and hyperprolinaemia type II.Arch. Dis. Child.82(3), 236–237 (2000).
  • Farrant RD , WalkerV, MillsGA, MellorJM, LangleyGJ: Pyridoxal phosphate de-activation by pyroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II.J. Biol. Chem.276(18), 15107–15116 (2001).
  • Baxter P : Pyridoxine-dependent seizures: a clinical and biochemical conundrum.Biochim. Biophys. Acta1647(1–2), 36–41 (2003).
  • Mills PB , StruysE, JakobsCet al.: Mutations in antiquitin in individuals with pyridoxine-dependent seizures.Nat. Med.12(3), 307–309 (2006).
  • Kuo MF , WangHS: Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine.Pediatr. Neurol.26(2), 146–147 (2002).
  • Clayton PT , SurteesRA, DeVile C, Hyland K, Heales SJ: Neonatal epileptic encephalopathy. Lancet361(9369), 1614 (2003).
  • Phang JM , HuCA, ValleD: Disorders of proline and hydroxyproline metabolism. In: The Metabolic and Molecular Bases of Inherited Disease. ScriverCR, BeaudetAL, SlyWSet al.: (Eds). McGraw-Hill, NY, USA, 1821–1838 (2001).
  • Flynn MP , MartinMC, Moore PT, Stafford JA, Fleming GA, Phang JM: Type II hyperprolinaemia in a pedigree of Irish travellers (nomads). Arch. Dis. Child.64(12), 1699–1707 (1989).
  • Hunt AD Jr, Stokes J Jr, McCrory WW, Stroud HH: pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics13(2), 140–145 (1954).
  • Been JV , BokLA, AndriessenP, RenierWO: Epidemiology of pyridoxine dependent seizures in the Netherlands.Arch. Dis. Child.90(12), 1293–1296 (2005).
  • Baxter P : Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK.Arch. Dis. Child.81(5), 431–433 (1999).
  • Nabbout R , SouffletC, PlouinP, DulacO: Pyridoxine dependent epilepsy: a suggestive electroclinical pattern.Arch. Dis. Child. Fetal Neonatal Ed.81(2), F125–F129 (1999).
  • Baxter P : Pyridoxine dependent epilepsy: a suggestive electroclinical pattern.Arch. Dis. Child. Fetal Neonatal Ed83(2), F163 (2000).
  • Baxter P , GriffithsP, KellyT, Gardner-MedwinD: Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient.Dev. Med. Child Neurol.38(11), 998–1006 (1996).
  • Baxter P : Pyridoxine-dependent and pyridoxine-responsive seizures.Dev. Med. Child Neurol.43(6), 416–420 (2001).
  • Ramachandran-Nair R , ParameswaranM: Prevalence of pyridoxine dependent seizures in south Indian children with early onset intractable epilepsy: a hospital based prospective study.Eur. J. Paediatr. Neurol.9(6), 409–413 (2005).
  • Cormier-Daire V , DagoneauN, NabboutRet al.: A gene for pyridoxine-dependent epilepsy maps to chromosome 5q31.Am. J. Hum. Genet.67(4), 991–993 (2000).
  • Bennett CL , HuynhHM, ChancePF, GlassIA, Gospe SM Jr: Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures. Neurogenetics6(3), 143–149 (2005).
  • Plecko B , HikelC, KorenkeGCet al.: Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy.Neuropediatrics36(3), 200–205 (2005).
  • Ito M , SekiT, TakumaY: Current therapy for West syndrome in Japan.J. Child Neurol.15(6), 424–428 (2000).
  • Ohtahara S , OhtsukaY, Yamatogi Y, Oka E, Yoshinaga H, Sato M: Prenatal etiologies of West syndrome. Epilepsia34(4), 716–722 (1993).
  • Pietz J , BenningerC, SchaferH, SontheimerD, MittermaierG, RatingD: Treatment of infantile spasms with high-dosage vitamin B6.Epilepsia34(4), 757–763 (1993).
  • Debus OM , KurlemannG: Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication.Epilepsia45(2), 103–108 (2004).
  • Wang HS , KuoMF, ChouMLet al.: Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy. Arch. Dis. Child.90(5), 512–515 (2005).
  • Baxter P : Pyridoxine or pyridoxal phosphate for intractable seizures?Arch. Dis. Child.90(5), 441–442 (2005).
  • Gospe SM Jr: Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment. Curr. Opin. Neurol.19(2), 148–153 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.